View in EDS HTML Full Text PDF Full Text

Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.

Saved in:
Bibliographic Details
Title: Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.
Authors: Faldu KG; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India., Shah JS; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India.
Source: Drug development research [Drug Dev Res] 2024 Nov; Vol. 85 (7), pp. e70017.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39533780
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Faldu+KG%22">Faldu KG</searchLink>; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Shah+JS%22">Shah JS</searchLink>; Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228204468%22">Drug development research</searchLink> [Drug Dev Res] 2024 Nov; Vol. 85 (7), pp. e70017.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8204468 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-2299 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202724391%22">02724391 </searchLink><i>NLM ISO Abbreviation: </i>Drug Dev Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39533780
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ddr.70017
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70017
    Titles:
      – TitleFull: Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Faldu KG
      – PersonEntity:
          Name:
            NameFull: Shah JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1098-2299
          Numbering:
            – Type: volume
              Value: 85
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Drug development research
              Type: main
ResultId 1